PMP22 and Charcot-Marie-Tooth disease type 1A: To identify novel biomarkers for CMT1A, we analyzed plasma samples from those obtained from 47 subjects with CMT1A and 41 control subjects from two independent CMT1A cohorts and two independent control cohorts.